3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2005-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2004.11.030PMID 15664848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials.

  2004cited by this paper
• Serotonergic targets in depression.

  2002cited by this paper
• SB‐272183, a selective 5‐HT1A, 5‐HT1B and 5‐HT1D receptor antagonist in native tissue

  2001cited by this paper
• Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase

  2001cited by this paper
• The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.

  2000cited by this paper
• History and evolution of the monoamine hypothesis of depression.

  2000cited by this paper
• Latency to paroxetine‐induced anxiolysis in the rat is reduced by co‐administration of the 5‐HT1A receptor antagonist WAY100635

  2000cited by this paper
• Mechanism of action of antidepressant medications.

  1999cited by this paper
• A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agent.

  1999cited by this paper
• [3H]5-HT binding to cloned human, dog, and rat 5-HT1D and 5-HT1B receptors.

  1998cited by this paper
• The use of antidepressant drugs in patients with heart disease.

  1998cited by this paper
• The use of pindolol to potentiate antidepressant medication.

  1998cited by this paper
• The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.

  1996cited by this paper
• Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo.

  1995cited by this paper
• Syntheses of (S)-(−)-pindolol and [3′-13C]-(R)-(−)-pindolol utilizing a lanthanum-lithium-(R)-BINOL ((R)-LLB) catalyzed nitroaldol reaction

  1994cited by this paper
• Clinical implication of microdialysis findings.

  1993cited by this paper
• 5-HT and antidepressants: new views from microdialysis studies.

  1993cited by this paper
• Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression

  1987cited by this paper

• Structural basis of vilazodone dual binding mode to the serotonin transporter

  2025cites this paper
• Structural basis of vilazodone dual binding mode to the serotonin transporter

  2025cites this paper
• Multitarget-Directed Ligands Hitting Serotonin Receptors: A Medicinal Chemistry Survey

  2024cites this paper
• Synthesis and Medicinal Importance of Benzoxazine, Benzoxazinone and Their Derivatives: A Short Review

  2021cites this paper
• Discovery of a novel dual-target inhibitor of ERK1 and ERK5 that induces regulated cell death to overcome compensatory mechanism in specific tumor types.

  2020cites this paper
• Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches.

  2017cites this paper
• Designing Approaches to Multitarget Drugs

  2017cites this paper
• Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology.

  2016cites this paper
• H3PW12O40 catalyzed synthesis of benzoxazine and quinazoline in aqueous media

  2014cites this paper
• Synthesis and Biological Screening of Novel Indolalkyl Arenes Targeting the Serotonine Transporter

  2014cites this paper
• Polypharmacology - foe or friend?

  2013cites this paper
• New design strategies for antidepressant drugs

  2013cites this paper
• Synthesis of fused heterocycles derived from 2H-1,4-benzoxazin-3(4H)-ones

  2013cites this paper
• Identification and Development of an Efficient Route to SB-649915

  2012cites this paper
• Classification of 5-HT1A receptor agonists and antagonists using GA-SVM method

  2011cites this paper
• Synthesis of pyrrole and indole quinoxalinone and oxazinone derivatives by intramolecular copper-catalyzed reactions.

  2011cites this paper
• 5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3.

  2010cites this paper
• Synthesis and structure-activity studies of benzyl ester meperidine and normeperidine derivatives as selective serotonin transporter ligands.

  2010cites this paper
• Synthesis of Quinoline-Bearing Ferrocene Derivatives via Friedlaender Reaction of Acetyl- and 1,1′-Diacetylferrocenes with o-Amino Aryl Aldehydes.

  2010cites this paper
• GSK 163090 ) , a Potent , Selective , and Orally Active 5-HT 1 A / B / D Receptor Antagonist

  2010cites this paper
• 2-Nitro-p-phenylene dibenzenesulfonate

  2010cites this paper
• Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist.

  2010cites this paper
• Recent advances in the discovery of selective and non-selective 5-HT(1D) receptor ligands.

  2010cites this paper
• Medicinal Chemistry Approaches for Multitarget Drugs

  2010cites this paper
• 4-Hydroxy-3-nitrophenyl pentanoate

  2010cites this paper
• Design and synthesis of novel tricyclic benzoxazines as potent 5-HT(1A/B/D) receptor antagonists leading to the discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045).

  2010cites this paper
• A cyclic trimer of 2-(2-aminophenoxy)propionic acid with a bowl-shaped structure

  2009cites this paper
• Designing multiple ligands - medicinal chemistry strategies and challenges.

  2009cites this paper
• N-Methylimidazole-promoted efficient synthesis of 1,3-oxazine-4-thiones under solvent-free conditions

  2009cites this paper
• [Strategy of molecular drug design: dual-target drug design].

  2009cites this paper
• Synthesis and in silico biological activity evaluation of new N-substituted pyrazolo-oxazin-2-one systems.

  2008cites this paper
• 2-Nitro-p-phenylene bis(toluenesulfonate)

  2008cites this paper
• Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives.

  2008cites this paper
• 3-Hydroxy-4-nitrophenyl acetate

  2008cites this paper
• Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter.

  2008cites this paper
• 5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders.

  2008cites this paper
• Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity.

  2008cites this paper
• Chapter 19 – Multitarget Drugs: Strategies and Challenges for Medicinal Chemists

  2008cites this paper
• Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.

  2008cites this paper
• First Scale-Up: Problems and Resolutions on the Synthesis of WAY-253752, a Novel, Dual-Acting SSRI/5HT1A Antagonist

  2008cites this paper
• 6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors.

  2008cites this paper
• Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor.

  2007cites this paper
• SB-649915-B, a Novel 5-HT1A/B Autoreceptor Antagonist and Serotonin Reuptake Inhibitor, is Anxiolytic and Displays Fast Onset Activity in the Rat High Light Social Interaction Test

  2007cites this paper
• 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors.

  2007cites this paper
• Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands.

  2007cites this paper
• Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy.

  2007cites this paper
• Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B

  2007cites this paper
• 3-Hydr­oxy-4-nitro­phenyl benzene­sulfonate

  2007cites this paper
• Differentiating antidepressants of the future: efficacy and safety.

  2007cites this paper
• Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century--a medicinal chemistry survey.

  2006cites this paper
• SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.

  2006cites this paper
• Recent Strategies for the Development of New Antidepressant Drugs

  2006cites this paper
• 4‐Hydr­oxy‐3‐nitro­phenyl benzene­sulfonate

  2006cites this paper
• 3‐Hydr­oxy‐4‐nitro­phenyl 4‐toluene­sulfonate

  2006cites this paper
• 3,4-Dihydro-2H-benzoxazinones are 5-HT1A Receptor Antagonists with Potent 5-HT Reuptake Inhibitory Activity.

  2005cites this paper
• Designed multiple ligands. An emerging drug discovery paradigm.

  2005cites this paper